Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP302130.RAUPq_bdALN2NM3bDY0AiWwoevaF6uaFHWNTnuua-s5LQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP302130.RAUPq_bdALN2NM3bDY0AiWwoevaF6uaFHWNTnuua-s5LQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP302130.RAUPq_bdALN2NM3bDY0AiWwoevaF6uaFHWNTnuua-s5LQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP302130.RAUPq_bdALN2NM3bDY0AiWwoevaF6uaFHWNTnuua-s5LQ130_provenance.
- NP302130.RAUPq_bdALN2NM3bDY0AiWwoevaF6uaFHWNTnuua-s5LQ130_assertion description "[Another finding showed that flavopiridol treatment induced a substantial AKT-Ser473 phosphorylation in human glioblastoma T98G cell line in contrast to siRNA-mediated inhibition of Cdk9 and Cdk9 combined with Cdk7, whereas siRNA-mediated silencing of Cdk7 caused a minor increase in AKT-Ser473 phosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP302130.RAUPq_bdALN2NM3bDY0AiWwoevaF6uaFHWNTnuua-s5LQ130_provenance.
- NP302130.RAUPq_bdALN2NM3bDY0AiWwoevaF6uaFHWNTnuua-s5LQ130_assertion evidence source_evidence_literature NP302130.RAUPq_bdALN2NM3bDY0AiWwoevaF6uaFHWNTnuua-s5LQ130_provenance.
- NP302130.RAUPq_bdALN2NM3bDY0AiWwoevaF6uaFHWNTnuua-s5LQ130_assertion SIO_000772 22391209 NP302130.RAUPq_bdALN2NM3bDY0AiWwoevaF6uaFHWNTnuua-s5LQ130_provenance.
- NP302130.RAUPq_bdALN2NM3bDY0AiWwoevaF6uaFHWNTnuua-s5LQ130_assertion wasDerivedFrom befree-20150227 NP302130.RAUPq_bdALN2NM3bDY0AiWwoevaF6uaFHWNTnuua-s5LQ130_provenance.
- NP302130.RAUPq_bdALN2NM3bDY0AiWwoevaF6uaFHWNTnuua-s5LQ130_assertion wasGeneratedBy ECO_0000203 NP302130.RAUPq_bdALN2NM3bDY0AiWwoevaF6uaFHWNTnuua-s5LQ130_provenance.
- befree-20150227 importedOn "2015-02-27" NP302130.RAUPq_bdALN2NM3bDY0AiWwoevaF6uaFHWNTnuua-s5LQ130_provenance.